The protein and mRNA levels of RanBP3 in CML cell lines (BCR-ABL+) were also higher compared with other control cells (BCR-ABL-) (Figures 1C–F). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.